BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 35384805)

  • 41. Outcomes of Donation After Circulatory Death Liver Grafts From Donors 50 Years or Older: A Multicenter Analysis.
    Croome KP; Mathur AK; Lee DD; Moss AA; Rosen CB; Heimbach JK; Taner CB
    Transplantation; 2018 Jul; 102(7):1108-1114. PubMed ID: 29952924
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Liver Transplantation for Hepatic Epithelioid Hemangioendothelioma Is Facilitated by Exception Points With Acceptable Long-term Outcomes.
    Brahmbhatt M; Prenner S; Bittermann T
    Transplantation; 2020 Jun; 104(6):1187-1192. PubMed ID: 31577674
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Graft-to-recipient weight ratio lower to 0.7% is safe without portal pressure modulation in right-lobe living donor liver transplantation with favorable conditions.
    Lee SD; Kim SH; Kim YK; Lee SA; Park SJ
    Hepatobiliary Pancreat Dis Int; 2014 Feb; 13(1):18-24. PubMed ID: 24463075
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Survival Outcomes in Split Compared With Whole Liver Transplantation.
    Chul Yoon K; Song S; Jwa EK; Lee S; Man Kim J; Kim OK; Kyun Hong S; Yi NJ; Lee KW; Soo Kim M; Hwang S; Suh KS; Lee SK
    Liver Transpl; 2018 Oct; 24(10):1411-1424. PubMed ID: 29747216
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Liver transplant recipients older than 60 years have lower survival and higher incidence of malignancy.
    Herrero JI; Lucena JF; Quiroga J; Sangro B; Pardo F; Rotellar F; Alvárez-Cienfuegos J; Prieto J
    Am J Transplant; 2003 Nov; 3(11):1407-12. PubMed ID: 14525602
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Minimizing Risk Associated With Older Liver Donors by Matching to Preferred Recipients: A National Registry and Validation Study.
    Haugen CE; Thomas AG; Garonzik-Wang J; Massie AB; Segev DL
    Transplantation; 2018 Sep; 102(9):1514-1519. PubMed ID: 29570165
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MELD score measured day 10 after orthotopic liver transplantation predicts death and re-transplantation within the first year.
    Rostved AA; Lundgren JD; Hillingsø J; Peters L; Mocroft A; Rasmussen A
    Scand J Gastroenterol; 2016 Nov; 51(11):1360-6. PubMed ID: 27319374
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Implications of Treating Hepatitis C Virus Infection Among Patients Awaiting Cadaveric Liver Transplant: A Single-Center Experience.
    Ofosu A; Durand CM; Saberi B; Alqahtani S; Ucbilek E; Belden M; Cameron AM; Gurakar A
    Exp Clin Transplant; 2015 Nov; 13 Suppl 3():7-10. PubMed ID: 26640901
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An analysis of outcomes of liver retransplant in adults: 12-year's single-center experience.
    Abdelfattah MR; Al-Sebayel M; Broering D
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():95-9. PubMed ID: 25894135
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Outcomes of liver transplantation with liver grafts from pediatric donors used in adult recipients.
    Croome KP; Lee DD; Burns JM; Saucedo-Crespo H; Perry DK; Nguyen JH; Taner CB;
    Liver Transpl; 2016 Aug; 22(8):1099-106. PubMed ID: 27145067
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of a Donor Age >75 Years on the Survival of Liver Transplant Recipients.
    Cuevas López MJ; Álvarez Aguilera M; Cepeda Franco C; Suárez Artacho G; Marín Gómez LM; Bernal Bellido C; Álamo Martínez JM; Padillo Ruiz FJ; Gómez Bravo MÁ
    Transplant Proc; 2022 Nov; 54(9):2525-2527. PubMed ID: 36319496
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Improvement in the Outcomes of MELD ≥ 40 Liver Transplantation: An Analysis of 207 Consecutive Transplants in a Highly Competitive DSA.
    Nekrasov V; Matsuoka L; Kaur N; Pita A; Whang G; Cao S; Groshen S; Alexopoulos S
    Transplantation; 2017 Oct; 101(10):2360-2367. PubMed ID: 28319564
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The evolution of liver transplantation during 3 decades: analysis of 5347 consecutive liver transplants at a single center.
    Agopian VG; Petrowsky H; Kaldas FM; Zarrinpar A; Farmer DG; Yersiz H; Holt C; Harlander-Locke M; Hong JC; Rana AR; Venick R; McDiarmid SV; Goldstein LI; Durazo F; Saab S; Han S; Xia V; Hiatt JR; Busuttil RW
    Ann Surg; 2013 Sep; 258(3):409-21. PubMed ID: 24022434
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Elderly Living Donor Liver Transplant Recipients Over 60 Years Old at a Japanese Single Center.
    Ushigome H; Nakao T; Harada S; Nakamura T; Koshino K; Suzuki T; Ito T; Nobori S; Yoshimura N
    Transplant Proc; 2016 May; 48(4):1115-8. PubMed ID: 27320569
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Favorable longterm outcomes of liver transplant recipients treated de novo with once-daily tacrolimus: Results of a single-center cohort.
    Gastaca M; Valdivieso A; Bustamante J; Fernández JR; Ruiz P; Ventoso A; Testillano M; Palomares I; Salvador P; Prieto M; Montejo M; Suárez MJ; de Urbina JO
    Liver Transpl; 2016 Oct; 22(10):1391-400. PubMed ID: 27434676
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HLA tissue typing has no effect on the outcome of patients undergoing a living-donor liver transplant: a single-center experience in Egypt.
    Yosry A; Said M; Esmat G; Al-Serafy M; Omar A; Doss W; Omran D; Saad Y; Kamel S; Abdel-Bary A; Hatata Y; Hosny A
    Exp Clin Transplant; 2012 Apr; 10(2):136-40. PubMed ID: 22432757
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of Underlying Liver Disease and Its Severity in Children Referred for Liver Transplant: a Single-Center Report From Nemazee Hospital of Shiraz.
    Dehghani SM; Shahramian I; Bazi A; Mohammadi Mofrad M; Mardani S
    Exp Clin Transplant; 2020 Dec; 18(7):803-807. PubMed ID: 30836904
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Liver Retransplantation Associated With Kidney Transplantation for End-stage Liver Graft Disease and Renal Insufficiency: A Morbid Procedure on a Unique Subgroup of Patients.
    Cauchy F; Vibert E; Cherqui D; Perdigao F; Sepulveda A; Samuel D; Calmus Y; Conti F; Adam R; Soubrane O; Scatton O
    Transplantation; 2020 Jul; 104(7):1403-1412. PubMed ID: 31651789
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of maintenance immunosuppression with sirolimus after liver transplant for hepatocellular carcinoma.
    Yanik EL; Chinnakotla S; Gustafson SK; Snyder JJ; Israni AK; Segev DL; Engels EA
    Liver Transpl; 2016 May; 22(5):627-34. PubMed ID: 26784951
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk factors for abdominal bleeding after living-donor liver transplant.
    Li C; Wen TF; Yan LN; Li B
    Exp Clin Transplant; 2014 Oct; 12(5):424-8. PubMed ID: 24568675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.